{"adverse_reactions":["ADVERSE REACTIONS To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc. at 1-877-845-0689 or FDA at 1-800-332-1088 or www.fda.gov/medwatch. \"1-800-FDA-1088\""],"effective_time":"20240209","id":"f38d180a-a6ba-4c42-9078-d2d00bf99e1a","openfda":{},"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL NDC 0143- 9141 -01 Rx only DOBUTamine Injection, USP 250 mg per 20 mL (12.5 mg/mL) For Intravenous Use ONLY Must be diluted prior to use Use within 24 hours after dilution 20 mL Single-Dose Vial NDC 0143- 9141 -10 Rx only DOBUTamine Injection, USP 250 mg per 20 mL (12.5 mg/mL) For Intravenous Use ONLY Must be diluted prior to use Use within 24 hours after dilution 10 x 20 mL Single-Dose Vials vial label carton label"],"set_id":"1b75c31c-f667-4f5f-b6cc-b2e881a90b18","spl_product_data_elements":["Dobutamine Dobutamine DOBUTAMINE HYDROCHLORIDE DOBUTAMINE SODIUM METABISULFITE HYDROCHLORIC ACID SODIUM HYDROXIDE WATER"],"version":"3"}